Complement activation and HLA-B27

about

Immune functions and inflammatory reactions in HLA-B27 positive subjects.Enhanced inflammatory reactivity in the pathogenesis of spondyloarthropathies.

P2860

Q37542520-BF4B5CB2-B71E-4442-9935-D53D2E997599 Q37804351-C873B9EF-0A78-495A-B668-0BD304771C52

P2860

Complement activation and HLA-B27

Item

http://www.wikidata.org/entity/Q33560757

description

1988 nî lūn-bûn

@nan

1988 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1988 թվականի մարտին հրատարակված գիտական հոդված

@hy

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

name

Complement activation and HLA-B27

@ast

Complement activation and HLA-B27

@en

Complement activation and HLA-B27.

@nl

type

Item

label

Complement activation and HLA-B27

@ast

Complement activation and HLA-B27

@en

Complement activation and HLA-B27.

@nl

prefLabel

Complement activation and HLA-B27

@ast

Complement activation and HLA-B27

@en

Complement activation and HLA-B27.

@nl

P1476

Complement activation and HLA-B27

@en

P2093

H Repo

http://www.w3.org/2001/XMLSchema#string

M Leirisalo-Repo

http://www.w3.org/2001/XMLSchema#string

S Meri

http://www.w3.org/2001/XMLSchema#string

P2860

Enhanced neutrophil migration in vivo HLA B27 positive subjects.

Why HLA-B27: an analysis based on two animal models.

Neutrophil aggregation and swelling induced by chemotactic agents.

Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

Genetic polymorphism in human glycine-rich beta-glycoprotein.

Inherited structural polymorphism of the fourth component of human complement

Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.

HL-A haplotypes of 32 diseases.

Structure and function of the anaphylatoxins.

Virulence-plasmid is associated with the inhibition of opsonization in Yersinia enterocolitica and Yersinia pseudotuberculosis.

P304

210-214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.47.3.210

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jukka Partanen

P577

1988-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19896813

http://www.w3.org/2001/XMLSchema#string

P698

3258504

http://www.w3.org/2001/XMLSchema#string

P932

1003485

http://www.w3.org/2001/XMLSchema#string

Complement activation and HLA-B27

about

P2860

P2860

Complement activation and HLA-B27

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932